Moderna to expand child vaccine trial to get more safety data
The Peninsula
Moderna Inc. said it would expand an ongoing trial of its coronavirus vaccine in kids under 12 years old to gather more safety data, amid worries that messenger RNA shots may trigger rare heart side effects.
"The objective is to enroll a larger safety database which increases the likelihood of detecting rarer events,” a Moderna spokeswoman said in a statement. Trial timelines are regularly re-evaluated based on regulatory agency discussions and requests, she said, but Moderna currently expects to have data that would support authorization in late 2021 or early 2022.
Islamic Cultural Center holds lecture on youth empowerment in Islam at Mesaieed International School
Doha, Qatar: With the attendance of 210 students, the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center organised a lecture entitled Youth E...
Doha, Qatar: The Ministry of Public Health (MoPH) has carried out an extensive inspection campaign that included a number of restaurants, cafes, and l...
Washington, USA: Amazon and Google announced the launch of a multi cloud networking service, jointly developed to meet the growing demand for reliable...
Doha, Qatar: Twenty students from the Community College visited the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center, where they learned abo...
London, UK: The Winter egg, one of Faberge s most dazzling creations, is due to be auctioned in London next week and set another sales price record fo...